Alnylam Pharmace. buy Citigroup Inc.
Start price
02.08.24
/
50%
€247.40
Target price
02.08.25
€313.41
Performance (%)
38.64%
End price
03.08.25
€343.00
Summary
This prediction ended on 03.08.25 with a price of €343.00. The BUY prediction by Citigroup_Inc_ for Alnylam Pharmace. saw massive gains of 38.64%. Citigroup_Inc_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Citigroup_Inc_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 1.180% | 1.180% | 70.344% |
| iShares Core DAX® | -1.150% | -0.950% | 26.606% |
| iShares Nasdaq 100 | 0.889% | 1.544% | 18.797% |
| iShares Nikkei 225® | 1.183% | 4.554% | 7.268% |
| iShares S&P 500 | 0.159% | 1.749% | 12.763% |
Comments by Citigroup_Inc_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Citigroup Inc. from $291.00 to $342.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€261.50
21.03.25
21.03.25
€323.45
21.03.26
21.03.26
47.61%
05.09.25
05.09.25
Stopped prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€384.10
02.09.25
02.09.25
€498.17
02.09.26
02.09.26
0.49%
05.09.25
05.09.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€269.40
11.07.25
11.07.25
€346.03
11.07.26
11.07.26
43.28%
05.09.25
05.09.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€225.00
25.06.24
25.06.24
€271.50
25.06.25
25.06.25
23.51%
26.06.25
26.06.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€136.40
16.02.24
16.02.24
€210.72
16.02.25
16.02.25
80.65%
17.02.25
17.02.25